BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 26000962)

  • 1. The Impacts of Migraine among Outpatients with Major Depressive Disorder at a Two-Year Follow-Up.
    Hung CI; Liu CY; Yang CH; Wang SJ
    PLoS One; 2015; 10(5):e0128087. PubMed ID: 26000962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Migraine: a missing link between somatic symptoms and major depressive disorder.
    Hung CI; Liu CY; Cheng YT; Wang SJ
    J Affect Disord; 2009 Sep; 117(1-2):108-15. PubMed ID: 19167091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impacts of migraine, anxiety disorders, and chronic depression on quality of life in psychiatric outpatients with major depressive disorder.
    Hung CI; Wang SJ; Yang CH; Liu CY
    J Psychosom Res; 2008 Aug; 65(2):135-42. PubMed ID: 18655858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of anxiety and migraine on quality of sleep in patients with major depressive disorder.
    Hsu SC; Wang SJ; Liu CY; Juang YY; Yang CH; Hung CI
    Compr Psychiatry; 2009; 50(2):151-7. PubMed ID: 19216892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impacts of migraine and anxiety disorders on painful physical symptoms among patients with major depressive disorder.
    Hung CI; Liu CY; Chen CY; Yang CH; Wang SJ
    J Headache Pain; 2014 Nov; 15(1):73. PubMed ID: 25382691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of migraine on patients with major depressive disorder.
    Hung CI; Liu CY; Juang YY; Wang SJ
    Headache; 2006 Mar; 46(3):469-77. PubMed ID: 16618265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbidities and factors related to discontinuation of pharmacotherapy among outpatients with major depressive disorder.
    Hung CI; Wang SJ; Liu CY; Hsu SC; Yang CH
    Compr Psychiatry; 2011; 52(4):370-7. PubMed ID: 21683174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Migraine and greater pain symptoms at 10-year follow-up among patients with major depressive disorder.
    Hung CI; Liu CY; Yang CH; Wang SJ
    J Headache Pain; 2018 Jul; 19(1):56. PubMed ID: 30019214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Migraine with active headache was associated with other painful physical symptoms at two-year follow-up among patients with major depressive disorder.
    Hung CI; Liu CY; Yang CH; Wang SJ
    PLoS One; 2019; 14(4):e0216108. PubMed ID: 31039196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Headache: an important factor associated with muscle soreness/pain at the two-year follow-up point among patients with major depressive disorder.
    Hung CI; Liu CY; Yang CH; Wang SJ
    J Headache Pain; 2016; 17():57. PubMed ID: 27233897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative impact of migraine on quality of life after 4 weeks of treatment in patients with major depressive disorder.
    Hung CI; Liu CY; Yang CH; Wang SJ
    Psychiatry Clin Neurosci; 2012 Feb; 66(1):8-16. PubMed ID: 22250605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent depressive disorder has long-term negative impacts on depression, anxiety, and somatic symptoms at 10-year follow-up among patients with major depressive disorder.
    Hung CI; Liu CY; Yang CH
    J Affect Disord; 2019 Jan; 243():255-261. PubMed ID: 30248637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Migraine predicts physical and pain symptoms among psychiatric outpatients.
    Hung CI; Liu CY; Wang SJ
    J Headache Pain; 2013 Feb; 14(1):19. PubMed ID: 23565902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale.
    Sheehan DV; Harnett-Sheehan K; Spann ME; Thompson HF; Prakash A
    Int Clin Psychopharmacol; 2011 Mar; 26(2):75-83. PubMed ID: 21102344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of intensity and special characteristics of migraine to depressive and anxious features.
    Anagnostou E; Constantinides V; Anagnostou E; Paraskevas G; Christidi F; Zalonis I; Stamboulis E; Kararizou E
    Psychiatriki; 2013; 24(3):197-201. PubMed ID: 24185086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual symptoms related to physical and panic symptoms at baseline predict remission of depression at follow-up.
    Hung CI; Liu CY; Wang SJ; Yang CH
    Psychopathology; 2014; 47(1):51-6. PubMed ID: 23652027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic symptoms: an important index in predicting the outcome of depression at six-month and two-year follow-up points among outpatients with major depressive disorder.
    Hung CI; Liu CY; Wang SJ; Juang YY; Yang CH
    J Affect Disord; 2010 Sep; 125(1-3):134-40. PubMed ID: 20064663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome.
    Howland RH; Rush AJ; Wisniewski SR; Trivedi MH; Warden D; Fava M; Davis LL; Balasubramani GK; McGrath PJ; Berman SR
    Drug Alcohol Depend; 2009 Jan; 99(1-3):248-60. PubMed ID: 18986774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiety does not predict response to duloxetine in major depression: results of a pooled analysis of individual patient data from 11 placebo-controlled trials.
    Nelson JC
    Depress Anxiety; 2010; 27(1):12-8. PubMed ID: 20013987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptoms of anxiety in depression: assessment of item performance of the Hamilton Anxiety Rating Scale in patients with depression.
    Vaccarino AL; Evans KR; Sills TL; Kalali AH
    Depress Anxiety; 2008; 25(12):1006-13. PubMed ID: 18800370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.